Autobio Diagnostics Co

Autobio Diagnostics Co P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Autobio Diagnostics Co (603658.SS) as of Oct 16, 2026 is 28.04. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 32.06 — a change of -12.54% (lower).

P/FCF

28.04

YoY

-12.54%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Autobio Diagnostics Co is 2025 28.04 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Autobio Diagnostics Co was 2024 32.06 . It decreases by -12.54% lower compared to the previous year.

The Autobio Diagnostics Co P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
84.89 CNY
Jan 1, 2019
255.83 CNY
Jan 1, 2020
-171.33 CNY
Jan 1, 2021
52.29 CNY
Jan 1, 2022
33.34 CNY
Jan 1, 2023
36.31 CNY
Jan 1, 2024
32.06 CNY
Jan 1, 2025
28.04 CNY
The Autobio Diagnostics Co P/FCF history
YEARP/FCFYoY
28.04-12.54%
32.06-11.70%
36.31+8.90%
33.34-36.24%
52.29-130.52%
-171.33-166.97%
255.83+201.38%
84.89-89.09%
778.21+571.53%
115.89-51.34%
238.14-10.31%
265.52—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Autobio Diagnostics Co Stock analysis

What does Autobio Diagnostics Co do? Autobio Diagnostics Co Ltd, listed on the Shanghai Stock Exchange under ticker 603658.SS, is a healthcare company based in Zhengzhou, China. The company specializes in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. With a workforce of 5,505 employees, Autobio Diagnostics went public on September 1, 2016. Its product portfolio includes immunodiagnostic reagents such as microplate chemiluminescence diagnostic reagents, enzyme-linked immunosorbent assay (ELISA) diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The company also offers microbiology detection products, including training detection reagents, susceptibility detection reagents, and rapid detection reagents. Device products encompass microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. Autobio Diagnostics primarily serves domestic markets within China, focusing on providing diagnostic solutions for healthcare applications. The company's headquarters is located in Zhengzhou, Henan Province, and it operates within the healthcare sector, specifically in the health care industry. Its website, https://www.autobio.com.cn/, provides further information on its services and products. Autobio Diagnostics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Autobio Diagnostics Co stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Autobio Diagnostics Co is 28.04 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Autobio Diagnostics Co changed from 32.06 to 28.04, representing a -12.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Autobio Diagnostics Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Autobio Diagnostics Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Autobio Diagnostics Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Autobio Diagnostics Co